Bicycle Therapeutics PLC
BCYC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761612
In the last 90 days, Bicycle Therapeutics PLC insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Bicycle Therapeutics PLC as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 82
- −23 vs. Q1 2022
- Shares held
- 22.7M
- +2.52M (+12.5%) vs. Q1 2022
- Total value
- $381.1M
- −$503.4M (−56.9%) vs. Q1 2022
- New holders
- 17
- 32 more added
- Sold out
- 40
- 16 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCYC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 103 | $157.9M |
| Q1 2026 | 98 | $173.6M |
| Q4 2025 | 109 | $276.9M |
| Q3 2025 | 99 | $285.6M |
| Q2 2025 | 110 | $286.3M |
| Q1 2025 | 95 | $354.4M |
| Q4 2024 | 97 | $586.5M |
| Q3 2024 | 105 | $915.3M |
| Q2 2024 | 107 | $804.0M |
| Q1 2024 | 95 | $759.1M |
| Q4 2023 | 101 | $567.4M |
| Q3 2023 | 101 | $651.3M |
| Q2 2023 | 85 | $618.5M |
| Q1 2023 | 89 | $498.9M |
| Q4 2022 | 87 | $695.9M |
| Q3 2022 | 79 | $538.0M |
| Q2 2022 | 82 | $381.1M |
| Q1 2022 | 105 | $884.5M |
| Q4 2021 | 101 | $1.31B |
| Q3 2021 | 69 | $591.1M |
| Q2 2021 | 54 | $376.9M |
| Q1 2021 | 39 | $341.2M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Bicycle Therapeutics PLC; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −21,572−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −17,954−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,700−100.0% | Sold out |
| Vestmark Advisory Solutions, Inc. | 0 | $0 | 0.00% | −9,906−100.0% | Sold out |
| Wrapmanager Inc | 0 | $0 | 0.00% | −8,835−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −7,991−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −7,770−100.0% | Sold out |
| Personal Cfo Solutions, LLC | 0 | $0 | 0.00% | −7,455−100.0% | Sold out |
| Twelve Points Wealth Management LLC | 0 | $0 | 0.00% | −7,100−100.0% | Sold out |
| TownSquare Capital, LLC | 0 | $0 | 0.00% | −7,088−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −6,436−100.0% | Sold out |
| Shilanski & Associates, Inc. | 0 | $0 | 0.00% | −5,502−100.0% | Sold out |
| Claro Advisors LLC | 0 | $0 | 0.00% | −3,637−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −2,129−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −1,999−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −270−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −183−100.0% | Sold out |
| American Portfolios Advisors | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Kayne Anderson Rudnick Investment Management LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |